![The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference | Pharmacogenomics The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/pgs.15.152/asset/images/medium/figure1.gif)
The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference | Pharmacogenomics
![Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment | Oncogene Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment | Oncogene](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41388-021-02170-0/MediaObjects/41388_2021_2170_Fig6_HTML.png)
Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment | Oncogene
![Cancers | Free Full-Text | Mechanisms Supporting the Use of Beta-Blockers for the Management of Breast Cancer Bone Metastasis Cancers | Free Full-Text | Mechanisms Supporting the Use of Beta-Blockers for the Management of Breast Cancer Bone Metastasis](https://www.mdpi.com/cancers/cancers-13-02887/article_deploy/html/images/cancers-13-02887-g001.png)
Cancers | Free Full-Text | Mechanisms Supporting the Use of Beta-Blockers for the Management of Breast Cancer Bone Metastasis
![The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors - Clinical Lung Cancer The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors - Clinical Lung Cancer](https://www.clinical-lung-cancer.com/cms/asset/519ac6a4-ee1d-4cdf-9d7f-3925cb6d4a10/gr1.jpg)
The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors - Clinical Lung Cancer
![Frontiers | Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression Frontiers | Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression](https://www.frontiersin.org/files/Articles/489789/fonc-09-01491-HTML/image_m/fonc-09-01491-g001.jpg)
Frontiers | Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
![Novel therapies emerging in oncology to target the TGF-β pathway | Journal of Hematology & Oncology | Full Text Novel therapies emerging in oncology to target the TGF-β pathway | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01053-x/MediaObjects/13045_2021_1053_Fig2_HTML.png)
Novel therapies emerging in oncology to target the TGF-β pathway | Journal of Hematology & Oncology | Full Text
![blocker and other therapeutic drugs were used to treat breast cancer... | Download Scientific Diagram blocker and other therapeutic drugs were used to treat breast cancer... | Download Scientific Diagram](https://www.researchgate.net/publication/49832592/figure/tbl1/AS:669672915607582@1536673873773/blocker-and-other-therapeutic-drugs-were-used-to-treat-breast-cancer-patients-for.png)
blocker and other therapeutic drugs were used to treat breast cancer... | Download Scientific Diagram
![Non-selective beta blockers exhibit higher efficacy than selective beta... | Download Scientific Diagram Non-selective beta blockers exhibit higher efficacy than selective beta... | Download Scientific Diagram](https://www.researchgate.net/publication/311945613/figure/fig6/AS:444263671570438@1482932121454/Non-selective-beta-blockers-exhibit-higher-efficacy-than-selective-beta-blockers-at.png)
Non-selective beta blockers exhibit higher efficacy than selective beta... | Download Scientific Diagram
![Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade](https://www.spandidos-publications.com/article_images/or/35/6/OR-35-06-3135-g00.jpg)
Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade
![Beta-Blockers Emerge As Beneficial In Early And Triple-Negative Breast Cancer: Reasons Why And The Role Of A Sympathetic Overdrive In TNBC Patients Beta-Blockers Emerge As Beneficial In Early And Triple-Negative Breast Cancer: Reasons Why And The Role Of A Sympathetic Overdrive In TNBC Patients](https://brainimmune.com/wp-content/uploads/2022/12/Beta-Blockers-Propranolol-Beneficial-Breast-Cancer.jpg)